Land: Ierland
Taal: Engels
Bron: HPRA (Health Products Regulatory Authority)
Dorzolamide
Santen OY
S01EC; S01EC03
Dorzolamide
20 milligram(s)/millilitre
Eye drops, solution in single-dose container
via the ocular route
30 x 0.2ml (2 sachets with 15 single dose containers); 60 x 0.2ml (4 sachets with 15 single dose containers)
Product subject to prescription which may be renewed (B)
Antiglaucoma preparations and miotics, Carbonic Anhydrase Inhibitors, dorzolamide
Carbonic anhydrase inhibitors; dorzolamide
It l is indicated: as adjunctive therapy to beta-blockers; as monotherapy in patients unresponsive to beta-blockers or in whom beta-blockers are contraindicated; in the treatment of elevated intra-ocular pressure in: ocular hypertension; open-angle glaucoma; pseudoexfoliative glaucoma.
Marketed
2006-06-02
PACKAGE LEAFLET: INFORMATION FOR THE USER TRUSOPT® PRESERVATIVE-FREE 20 MG/ML EYE DROPS, SOLUTION IN SINGLE-DOSE CONTAINER dorzolamide READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What TRUSOPT Preservative-Free is and what it is used for 2. What you need to know before you use TRUSOPT Preservative-Free 3. How to use TRUSOPT Preservative-Free 4. Possible side effects 5. How to store TRUSOPT Preservative-Free 6. Contents of the pack and other information 1. WHAT TRUSOPT PRESERVATIVE-FREE IS AND WHAT IT IS USED FOR TRUSOPT Preservative-Free contains dorzolamide which belongs to a group of medicines called "carbonic anhydrase inhibitors". This medicine is prescribed to lower raised pressure in the eye and to treat glaucoma. This medicine can be used alone or in addition to other medicines which lower the pressure in the eye (so-called beta- blockers). 2. WHAT YOU NEED TO KNOW BEFORE YOU USE TRUSOPT PRESERVATIVE-FREE DO NOT USE TRUSOPT PRESERVATIVE-FREE - if you are allergic to dorzolamide hydrochloride or any of the other ingredients of this medicine (listed in section 6). - if you have severe kidney impairment or problems, or a prior history of kidney stones. If you are not sure whether you should use this medicine, contact your doctor or pharmacist. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before using TRUSOPT Preservative-Free. Tell your doctor or pharmacist about any medical problems you have now or have had in the past, including eye problems and eye surgeries, and about any all Lees het volledige document
Health Products Regulatory Authority 01 March 2023 CRN00DDHK Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT TRUSOPT Preservative-Free 20 mg/ml eye drops, solution in single-dose container 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 22.26 mg of dorzolamide hydrochloride equivalent to 20 mg of dorzolamide and one drop contains approximately 0.8 mg of dorzolamide hydrochloride equivalent to 0.7 mg of dorzolamide. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution in single-dose container Clear, colourless to nearly colourless, slightly viscous solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS TRUSOPT Preservative-Free 20 mg/ml is indicated: · as adjunctive therapy to beta-blockers, · as monotherapy in patients unresponsive to beta-blockers or in whom beta-blockers are contraindicated, in the treatment of elevated intra-ocular pressure in: · ocular hypertension, · open-angle glaucoma, · pseudoexfoliative glaucoma. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology When used as monotherapy, the dose is one drop of dorzolamide in the conjunctival sac of the affected eye(s), three times daily. When used as adjunctive therapy with an ophthalmic beta-blocker, the dose is one drop of dorzolamide in the conjunctival sac of the affected eye(s) two times daily. When substituting dorzolamide for another ophthalmic anti-glaucoma agent, discontinue the other agent after proper dosing on one day, and start dorzolamide on the next day. If more than one topical ophthalmic drug is being used, the drugs should be administered at least ten minutes apart. Patients should be instructed to wash their hands before use and avoid allowing the tip of the container to come into contact with the eye or surrounding structures. Patients should also be instructed that ocular solutions, if handled improperly, can become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may Lees het volledige document